Top Markets
#1 GALA GALA +36.97%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +34.71%
#3 Magma Finance Magma Finance +34.06%
#4 Useless Coin Useless Coin +32.17%
#5 Ethereum Name Service Ethereum Name Service +31.33%
#6 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +30.25%
#7 Bitcoin Cash Bitcoin Cash +29.80%
#8 Talus Network Talus Network +29.32%
#9 Pepe Pepe +29.19%
#10 Binance-Peg ZEC Binance-Peg ZEC +28.95%
Coin of the day
GALA GALA
Settings
Language
ENGLISH
Currency
USD
Theme
Heat Biologics, Inc. Heat Biologics, Inc.

Heat Biologics, Inc.

HTBX
Rank in Stocks #24400
Heat Biologics, Inc. is an integrated biopharmaceutical company focused on... Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two key components: ImPACT, an allogenic cell-based system designed to stimulate and proliferate T-cells as an immune activator, and ComPACT, a singular product engineered to achieve both antigen-driven T-cell activation and specific co-stimulation simultaneously. Their development pipeline includes several clinical-stage assets. HS-110 has finished enrolling patients for its Phase II trial targeting advanced non-small cell lung cancer, while HS-130 is currently in a Phase I clinical trial for advanced solid tumors. Furthermore, PTX-35, a novel T-cell co-stimulator agonist antibody that acts on DR3/TNFRSF25, is being evaluated in a Phase I clinical trial for diverse immunotherapy applications. The company is also advancing a COVID-19 vaccine, which is currently in the preclinical stage. Heat Biologics, Inc. has partnered with Dr. James Shapiro at the University of Alberta to develop a surrogate mouse version of PTX-35. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.
Share Price
$2.38
Last synced: 2022-05-03
Market Cap
$61.07M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Heat Biologics, Inc. (HTBX)

Category

Healthcare
Dividend history for Heat Biologics, Inc. (HTBX)
Heat Biologics, Inc. (stock symbol: HTBX) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Heat Biologics, Inc. (HTBX) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH